The product is specific for Ocrelizumab. This antibody serves as an excellent positive control for Ocrelizumab immunogenicity (ADA) assays.
Endotoxin level
Please contact with the lab for this information.
Purification
Purified by antigen affinity column.
Accession
CAS: 637334-45-3
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Application
ELISA | IHC | WB
Dilution
1:5000-1:20000 | 1:50-1:500 | 1:500-1:2000
Stability and Storage
The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles.
Background
Ocrelizumab (Ocrevus®) is an intravenously administered, humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS). Antibodysystem Anti-Ocrelizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ocrelizumab.
Caption
Western blot analysis was performed using anti-Ocrelizumab polyclonal antibody at 1ug/mL on recombinant Ocrelizumab (Catalog No.:TD-HY257026).